DataMEDS AI Establishes “Health Lives Here” Community Respiratory Program for Corexa Health Pharmacy Network
Being marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmaciesTo be launched first at Corexa Pharmacy in Lakeland, FL...
Day: October 23, 2026
Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal cancer
Faster and higher expansion of tumor-targeting CD8 T cells associated with longer overall survival in previously treated mismatch repair proficient...
Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01
EVX-01 induced an immune response in all patients in the trial with 89% of the vaccine neoantigens generating potent specific...
IBA signs major contract for a high-throughput Be Efficient sterilization solution in Germany
Louvain-la-Neuve, Belgium, October 23, 7 a.m. – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and...
Santhera’s Licensing Partner, Nxera Pharma, Submits Marketing Authorization Application for AGAMREE® (Vamorolone) in South Korea
Pratteln, Switzerland, October 23, 2026 – Santhera Pharmaceuticals (SIX: SANN) today notes that its licensing partner Nxera Pharma Co., Ltd....
Fangzhou Showcases Award-Winning AI Chronic Care Solution at Fortune China 500 Forum
CHENGDU, China, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of...
Orange Hospice Receives BusinessRate Best of 2026 Award as a Hospice in Orange County
Buena Park recognition reflects more than 40 five-star family reviews as the provider marks five years of hospice care in...
Lycia Therapeutics Announces Pricing of Upsized Initial Public Offering
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (“Lycia”) (Nasdaq: LYCA), a clinical-stage biotechnology company...
Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026
In the large, pivotal Phase 3 Launch-HTN trial, lorundrostat achieved similar significant blood pressure reductions in participants with and without...
Immuron CEO, Steven Lydeamore presentation at Emerging Growth Conference
MELBOURNE, Australia, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief...
Enlivex Announces 1-for-16 Reverse Share Split to be Effective October 27, 2026
Nes-Ziona, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "Company"), a quality longevity company...
Delta Dental Foundation of North Carolina Commits $1 Million to Expand Oral Health Access Statewide
Investments target children's and adult oral health and growing the workforce that makes access and dental care possible Delta Dental...
Park Family & Cosmetic Dentistry Named Best Cosmetic Dentistry Practice in Naples, FL
The locally owned cosmetic and family dental practice won the Cosmetic Dentistry category of the 2026 Naples Community's Choice Awards...
CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
MINNEAPOLIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing,...
FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026
Company to host conference call and webcast on Thursday, November 5 at 4:30 p.m. ETFocalTherics™ to Announce Third Quarter 2026...
CORRECTION — Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
Clears Pathway for Execution of Future R&D Milestone Events such as the Phase 1b, FIH Study for PRP in up...
VisCardia Announces Publication of RECOVER-HF Pilot Trial in JACC: Heart Failure
Publication marks a milestone for VisONE™ cardiac diaphragm support as enrollment continues in the RECOVER-HF pivotal IDE trialPORTLAND, Ore., Oct....
Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar
Patient advocacy initiative expands its reach with a nationally recognized voice on health, resilience and informed treatment decisionsTORONTO, Oct. 22,...
Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
GAITHERSBURG, Md., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting...
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional...